Pamela Tenaerts

@PamelaTenaerts

MD MBA Exec Director Duke Ironman 🇧🇪🇺🇸 Twts my own, indepndnt of CTTI. Links/RTs r not endorsements.

Vrijeme pridruživanja: listopad 2012.

Tweetovi

Blokirali ste korisnika/cu @PamelaTenaerts

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @PamelaTenaerts

  1. 2. velj

    4 reasons you need to listen to this webinar 1) is a cornerstone of well-designed 2) is featured in the renovation 3) is one of area of focus 4) will be part of our to be released

    Poništi
  2. proslijedio/la je Tweet
    28. sij

    Engaging patients at every stage of clinical research is no longer a “should,” it is a “must”. Jaye Bea Smalley & ’s Joe DiMasi discuss resources during a CTTI webinar 2/27:

    Poništi
  3. proslijedio/la je Tweet
    22. sij

    Webinar now available: CTTI shares recs for evaluation of the single IRB implementation process, as well as existing resources that can help you with implementation today!

    Poništi
  4. proslijedio/la je Tweet
    21. sij

    A strong cross-institutional infrastructure & solid comms approach are critical to achieving long-term sustainability of . Read more findings from a recent meeting

    Poništi
  5. proslijedio/la je Tweet
    9. sij

    Need help meeting requirements? Want to hear about the outcomes from a recent collaboration between CTTI and a NIH sIRB policy workgroup? Join this webinar to learn more.

    Poništi
  6. 8. sij

    Not to be missed if you are conducting multi-center in the US. It will be required for funded trials but an booster for other sponsored and trials as well.

    Poništi
  7. 29. pro 2019.

    While our executive members never really leave the CTTI family I would like to thanks Dalvir Gill () John Hubbard and for their dedication to improving clinical trials. Their thoughts, comments and humor will be missed at our meetings.

    Poništi
  8. proslijedio/la je Tweet
    20. pro 2019.

    Thank you for working with CTTI to achieve many accomplishments in 2019, incl new recs & resources to help create more efficient . Wishing you all a wonderful holiday season & we look forward to working with you in the year ahead!

    Poništi
  9. proslijedio/la je Tweet
    16. pro 2019.

    Decentralized are not “all or nothing”—they exist in a broad continuum. Read more about recs that can help you navigate options in ’s TIRS journal

    Poništi
  10. proslijedio/la je Tweet
    16. pro 2019.

    Bayesian response adaptive platform trial in The Lancet investigating oseltamivir. Congrats and entire team!

    Poništi
  11. proslijedio/la je Tweet
    10. pro 2019.

    To fully leverage technology within clinical trials, including & , collaboration from many diverse stakeholders is needed, according to a paper published in that shared conclusions from a . More:

    Poništi
  12. proslijedio/la je Tweet

    The FDA’s large portfolio of activities to integrate patient engagement throughout the agency was highlighted during a recent CTTI-hosted webinar - View the webinar here >>

    Poništi
  13. proslijedio/la je Tweet
    10. pro 2019.

    TODAY! webinar “Clinical Trials in Special Patient Populations”: CTTI will highlight how its & engagement recs can help expand participation in

    Poništi
  14. 11. pro 2019.

    Conducting trials at the participants easiest location when possible is they way we need to move forward. These recommendations help you get through barriers to do just that. More info here:

    Poništi
  15. 11. pro 2019.

    Thank you for your service on the executive committee of . Your thoughtfulness helped us improve efficiency and quality of tremendously. Good luck in your next adventure!

    Poništi
  16. 9. pro 2019.
    Poništi
  17. 9. pro 2019.

    congratulations! Will the recommendations become live on your website?

    Poništi
  18. proslijedio/la je Tweet
    9. pro 2019.

    TOMORROW! Listen as presenters tackle patient & issues and discuss how CTTI’s recs can help

    Poništi
  19. proslijedio/la je Tweet

    Good data is essential for tracking when bacteria become resistant to . But not all countries have the information they need to 🦠💊 Updated figures from show what can be done with electronic health records: |

    Poništi
  20. 19. stu 2019.

    Chibuzor Uchea from Laying out the case for an international network running a continuous FDA-IDSA-NIH-PEW

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·